Immunogenicity Expert and FDA Alum Dr. Amy Rosenberg Joins EpiVax
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
PROVIDENCE, R.I., July 6, 2021 /PRNewswire-AsiaNet/ -- EpiVax, Inc. ("EpiVax") is pleased to announce that Dr. Amy Rosenberg is leaving the FDA's Division of Therapeutic Proteins, CDER, which she led for over 20 years, to join EpiVax as Senior Director of Immunology and Protein Therapeutics. Logo ...
Authors: LATEST ASIANET NEWS RELEASES